Atlas Trials

Platinum Sensitive Ovarian Cancer (PSOC)

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Platinum Sensitive Ovarian Cancer (PSOC)

RecordFirmDate
Trastuzumab Rezetecan and Carboplatin ± Bevacizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-sensitive Recurrent Ovarian Cancer (NCT07776171)Sun Yat-sen University2026-09-30
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) (NCT05579366)Genmab2022-12-07

Track Platinum Sensitive Ovarian Cancer (PSOC) automatically

Every clearance here is in the API, with alerts when new ones post.